熱門資訊> 正文
生物技术公司Scorpius上半年收入增长三倍，获得1，440万美元融资
2024-08-26 21:19
- Biotech company Scorpius Holdings (NYSE:SCPX) CEO Jeff Wolf said on Monday in a letter to shareholders that the company has recorded a threefold increase in revenue for the first half of 2024.
- Scorpius’ current sales pipeline now includes more than $100M in opportunities across the biopharmaceutical and government sectors.
- The company has recently completed a round of financing, raising about $14.4M in gross proceeds, Wolf added in his letter.
- The funds will help Scorpius to provide better services and attract customers, enabling the biotech company to diversify its customer base with both commercial and government opportunities.
- The company has also started transitioning several of its key clients from process development phase into full-scale manufacturing to enable additional revenue stream.
- Shares of Scorpius were down 3.33% during pre-market trading.
More on Scorpius Holdings
- Financial information for Scorpius Holdings
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
